BACKGROUND: Adiponectin is a collagen-like plasma protein speci®cally synthesized in adipose tissue. Plasma adiponectin concentrations are decreased in obesity whereas it is adipose-speci®c. OBJECTIVE: To clarify the signi®cance of the genetic variations in adiponectin gene on its plasma concentrations and obesity. SUBJECTS: Two hundred and nineteen unrelated adult Japanese subjects (123 men and 96 women, age: 20 ± 83 y, BMI: 16 ± 43 kgam 2 ) including 77 obese subjects (BMI b 26.4 kgam 2 ). MEASUREMENT: Human adiponectin gene was isolated from PAC DNA pools. Mutations in the adiponectin gene were screened by direct sequencing or restriction-fragment polymorphism. The levels of plasma adiponectin were determined by the enzyme-linked immunosorbent assay (ELISA). RESULTS: Adiponectin gene spanned 17 kb on chromosome 3q27, consisting of three exons and two introns. Within 2.1 kb of the 5 H -¯anking region, there were two octamer elements present in the promoter of adipsin. Two nucleotide changes were identi®ed. One was a polymorphism (GaT) occurring in exon 2, and the other was a missense mutation (R112C) in exon 3. The mean plasma adiponectin levels of the subjects carrying G allele were low (GaG: 4.5 mgaml; GaT: 5.9 mgaml; and TaT: 6.3 mgaml), but were not statistically signi®cant. The allelic frequency between the obese and the non-obese showed no signi®cant difference. The subject carrying R112C mutation showed markedly low concentration of plasma adiponectin. CONCLUSION: Two nucleotide changes have been identi®ed in the adiponectin gene. GaT polymorphism in exon 2 was associated with neither plasma adiponectin concentrations nor the presence of obesity. A subject carrying missense mutation (R112C) showed markedly low plasma adiponectin concentration.
Introduction
Obesity, de®ned as accumulation of excess body fat, is a major health problem in the industrial countries and a major risk factor for non-insulin dependent diabetes mellitus and vascular diseases. Several lines of evidence have shown that adipose tissue not only stores a large quantity of fat as an energy source, but also secretes a variety of proteins that in¯uence the metabolism of the body. These physiologically active molecules derived from adipocytes are`adipocytokines'. 1, 2 Adipsin was isolated from the adipocytes and proved to be one of the complement components. 3 Tumor necrosis factor (TNF) a overproduced in adipose tissue is involved in the development of insulin resistance. 4 Plasminogen activator inhibitor-1 (PAI-1), synthesized in adipose tissue, is involved in the development of thrombotic vascular diseases. 2 Further, the discovery of the obese gene opened up a new ®eld in obesity research. 5 The gene product, leptin, is secreted speci®cally from adipocytes to regulate energy balance by reducing food intake and increasing energy expenditure. Leptin is involved in transmitting a satiety signal to the brain to reduce food intake and increase energy expenditure of the body.
Identi®cation of adipose-speci®c genes should provide a clue to understand the biological signi®cance of adipocytes. Through systematic survey of active genes in human adipose tissue using random complementary DNA (cDNA) sequencing, we have previously isolated a cDNA, apM1 (adipose most abundant gene transcript 1), which is speci®cally and abundantly expressed in adipose tissues. 6 The cDNA encoded a plasma protein highly homologous to collagen VIII, X and complement factor C1q. Since the gene product was predicted to be a kind of matrix protein synthesized by adipose tissue, we named it adiponectin.
were decreased in obesity. 7 Analysis of gene structure and identi®cation of mutations will give rise to the understanding of the mechanism of the decreased plasma adiponectin. In this study, we analyzed the genomic organization and chromosomal localization, and identi®ed mutations in human adiponectin gene. H in combination with adaptor primer 1 (Clontech). The transcription initiation site was determined by RNase protection assay.
Materials and methods

Isolation
Radiation-hybrid mapping
Mapping was carried out using the Gene Bridge 4 Radiation Hybrid Panel (Research Genetics) according to the manufacturer's instructions, using speci®c primers designed to amplify the sequence between intron 1 and intron 2 containing the exon 2 region of the adiponectin gene. 8 The levels of plasma adiponectin were determined by the enzyme-linked immunosorbent assay (ELISA) system using monoclonal antibodies against human recombinant adiponectin as previously reported. 7 We isolated the genomic DNA of 219 subjects from peripheral blood leukocytes. The entire translated region and part of the 5 H -untranslated region of adiponectin gene (encoding exons 2 and 3) were ampli®ed by PCR using two pairs of speci®c primers. One pair consisted of 5
H -GAAGTAGACTCTGCTGA-GATGG-3
H and 5
H , which¯ank the region containing exon 2, and the other pair consisted of 5
H , which¯ank the region containing exon 3. The PCR products were directly sequenced on an ABI 377 automatic sequencer or followed by a PCR-based assay for the analysis of restriction fragment length polymorphisms. The PCR products containing exon 2 (372 bp) were digested with SmaI endonuclease to yield the restriction fragment and separated on a 2% agarose gel. The gel was stained with ethidium bromide and photographed under ultraviolet illumination.
Statistical analysis
Statistical analysis were performed by means of the Mann ± Whitney U-test or w 2 analysis.
Results
Genomic structure and promoter sequence
Two positive P1-derived arti®cial chromosome (PAC) clones (PAC116-D-11 and PAC93-M-21) were isolated by screening of human PAC DNA library using the primers for adiponectin gene. Sequencing of DNA revealed that both clones contained the entire coding sequence of adiponectin gene. DNA from PAC116-D-11 was used for further analysis. The nucleotide sequences of the exonaintron boundaries and the size of the exons and introns are presented in Figures 1 and  2 . Analysis of the exon ± intron boundaries showed that the human adiponectin gene contained three exons within 17 kb of genomic DNA with a large ®rst intron (Figure 1 ), indeed resembling the structure of human collagen X gene, 9 which has signi®cant homology with adiponectin. 6 All of the exon ± intron boundaries were consistent with the AGaGT rule 10 To analyze the promoter region of the gene, a 2.9 kb XbaI-BamHI fragment with exon 1 was subcloned and sequenced entirely. It contained approximately 2.1 kb of the 5 H -¯anking region of exon 1 ( Figure 2 ). The 1.3 kb 5
H -¯anking sequence of human adiponectinaapM1 gene has been reported by Schaf¯er et al.
11
A search of the promoter region for canonical consensus sequences revealed the presence not of a consensus TATA box, but of a classical CCAAT box at À136 and several putative binding sites for transcription factors. We found some transcriptional factor binding sites such as CaEBP (CCAAT enhancer binding protein) and RORa1 (RAR-related orphan receptor) known to regulate the differentiation and adipogenesis of the adipocytes as previously described. 11 Further, we found another E box at À1742 and two consensus sequences in the region between À1.3 and À2.1 kb. A CACCA motif, one of the common short elements present in the promoter of genes, such as lipoprotein lipase participating in the differentiation of the adipocytes was found at À1691. 12 We also identi®ed a core sequence of glucocorticoid-dependent regulatory element at À1578. 13 These elements in the promoter also seem to in¯uence the fat-speci®c expression of adiponectin gene. Adipsin is a gene exclusively expressed in the adipocytes and negatively regulated in obese animals. 14 Compared to the promoter of the adipsin gene, we identi®ed two octamer elements at À233a À226 CCCAAGCT, and À328aÀ321 TTGCCCCA, corresponding perfectly to the sequences in the 56 bp fragment ORE (obesity regulatory element). ORE has been proven to be necessary for negative regulation of adipsin gene. 15 
Chromosomal localization
We determined a precise localization of the human adiponectin gene by means of the Gene Bridge 4 Radiation Hybrid Panel using speci®c primers designed to amplify the sequence containing the exon 2 region. The data are shown in Table 1 . The human adiponectin gene was mapped between markers D3S1571 and D3S1580. We assumed that the LOD score of 15 is faithful enough to assume their linkages. The gene was placed 8.23 cR from D3S1571 of the chromosome 3q27. The genes for thrombopoietin 16 and 100 kDa complement-activating components of Ra-reactive factor 17 were mapped to chromosome 3q27. The deletion and translocation of 3q27 have been reported in minor facial dysmorphism 18 and nonHodgkin's lymphoma, 19 respectively.
Genotype analysis of the gene for adiponectin
Since adiponectin is a secretory protein present in plasma, we have established a enzyme-linked immunosorbent assay (ELISA) system for the determination of plasma adiponectin concentrations. We found that its plasma levels were decreased in obesity while the expression of adiponectin gene was exclusively restricted in adipose tissue. 7 Plasma adiponectin level may also be regulated by genetic variation.
We measured plasma concentrations of adiponectin in 219 unrelated Japanese subjects including 123 men (mean ( AE s. ). The plasma insulin levels (mean AE s.d.) were higher in obese subjects (men 12.0 AE 8.4 mUaml, women 11.6 AE 6.3 mUaml) than non-obese subjects (men 6.9 AE 4.1 mUaml, women 8.0 AE 5.9 mUaml). Plasma adiponectin concentrations varied from 0.42 to 27.3 mgaml and decreased in the obese as previously reported. 7 No signi®cant correlation was found between plasma adiponectin concentrations and plasma insulin levels.
To ®nd out the genetic variations associated with decreased plasma concentration, we ampli®ed and sequenced entire coding regions of the adiponectin genes in all subjects. Two nucleotide changes have been identi®ed in 438 alleles of adiponectin gene. One was a G to T substitution at nucleotide 94 in exon 2 ( Figures 2 and 3b and Table 2 ). With the glycine codon GGG in position 15, the nucleotide exchange to GGT causes no amino acid conversion (G15G). Thus, it was a silent polymorphism. The other was a C to T substitution at nucleotide 383 in exon 3 (Figures 2 and  3d) . With the arginine codon CGC in position 112, the nucleotide exchange to TGC predicts the amino acid conversion from arginine to cysteine. Thus, it was a missense mutation (R112C).
We examined whether the mutations in adiponectin gene are associated with its plasma level or obesity. For G15G polymorphism, a PCR-based assay for the analysis of restriction fragment length polymorphism was performed (Figure 4 ). There was a SmaI recognition site surrounding G nucleotide at 94. When the PCR-products of exon 2 (372 bp) obtained from Figure 4 , lane 1). In DNA from a homozygote for TaT allele, the PCR products was not cleaved, remaining as a 372 bp single band ( Figure  4 , lane 3). Among 142 non-obese subjects, 71 (50%) were homozygous for TaT, 61 (43%) were GaT heterozygotes, and 10 (7%) were homozygous for the GaG ( Table 2 ). The frequency of the T allele was 71%, indicating that this was a frequent polymorphism and T allele was predominant in the population. The mean ( AE s.d.) plasma adiponectin levels of the subjects with GaG, GaT and TaT allele were 4.5 AE 2.9 mgaml, 5.9 AE 4.3 mgaml, and 6.3 AE 4.5 mga ml, respectively. Mean plasma adiponectin level in the subjects having G allele was low, but it was not statistically signi®cant. Next, we compared the frequency of T allele in non-obese and obese subjects. Among 77 obese subjects, 33 (42%) were homozygous for TaT, 38 (49%) were GaT heterozygotes, and 6 (8%) were homozygous for the GaG (Table 2 ). Allelic frequency of T was 71%, respectively, resulting in no signi®cant difference between non-obese Figure 4 Results of polymerase-chain-reaction (PCR) screening for polymorphism in the gene for adiponectin. PCR ampli®cation of DNA, followed by restriction-enzyme digestion and ethidium bromide-stained agarose-gel electrophoresis, was performed as described in the Materials and Methods section. When applied to a DNA sample that was homozygous for the GaG alleles at nucleotide 94 (lane 1), the restriction endonuclease SmaI cut the entire DNA sample into two fragments. In DNA from a sample heterozygous for the GaT alleles, fragments of three sizes were observed (lane 2). In DNA from a sample homozygous for the TaT alleles, the fragment ampli®ed by PCR was not cleaved by the restriction enzyme, resulting in a single band (lane 3).
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and obese subjects. We also analyzed the relationship between the polymorphism and the metabolic parameters affected by adipose tissue functions such as plasma levels of glucose, insulin, cholesterol, triglyceride and HDL-cholesterol. These parameters were not signi®cantly different among the three groups. The R112C proband carried the mutation with a heterozygous form. His plasma adiponectin concentration was as low as 1.16 mgaml compared with the average concentration of non-obese men of 7.7 AE 3.1 mgaml as previously reported, 7 whereas his BMI was normal as 25.3 kgam 2 . He suffered from coronary artery disease, lung thrombosis and autoimmune disease. He had one son and three daughters. Among them, only the second daughter carried the R112C mutation. She showed the low concentration of plasma adiponectin as 4.3 mgaml in spite of her normal BMI (21.5 kgam 2 ), whereas the ®rst and third daughters carrying no mutation showed 20.0 and 14.6 mgaml, respectively ( Figure 5 ).
Discussion
The human body is composed of various types of cells. Each cell expresses a large number of housekeeping genes, required for cells to live, and fewer cell-speci®c genes to exert the specialized functions of the cell. Analysis of cell-type-speci®c genes will provide us with valuable information to understand the function of the cells. Several adipose-speci®c genes including aP2, adipsin 3 and leptin 5 have been isolated. Adiponectin is a novel gene exclusively expressed in human adipose tissue. In the current study, we have shown that adiponectin gene spanned 17 kb on chromosome 3q27, consisting of three exons and two introns. It shares signi®cant homology with collagen X, VIII and complement factor C1q, and contains a collagenous structure at the NH2 terminus and a globular domain at the COOH terminus. 6 The translated region was interrupted by a single intron resembling the situation of human collagen X, 9 VIII 20 and C1q 21 genes (Figure 1 ). C1q protein forms a characteristic superstructure in which three protomers trimerize to form a collagen triple helix, and three trimers multimerize to form a`bouquet'. 22 When viewed under the electron microscope, C1q protein appeared to bend at Gly36 in the middle of triplehelical chains corresponding to the point divided into two exons. Accordingly, it is possible that the boundary of two exons in the adiponectin gene corresponds to a bend in the collagen triplex formation.
The expression of adiponectin is especially limited to adipose tissue. Adiponectin had homology to mouse adipoQaAcrp30 with 85% at cDNA level and with 83% at amino acid level, respectively. It has been reported that AdipoQ 23 or Acrp30 24 mRNA was induced more than 100-fold during differentiation of 3T3 preadipocytes 24 and AdipoQ mRNA levels in adipose tissue were markedly reduced in the obese. 23 We observed that the adiponectin concentrations in plasma negatively correlated with the degree of human obesity. 7 DNA fragment containing À1332 bp of adiponectin gene possessed promoter activity in 3T3-L1 adipocytes. 11 Adipsin is a protein predominantly produced by adipose tissue. 3 Expression of adipsin mRNA in adipose tissue is negatively regulated and its plasma concentrations are markedly decreased in obese rodents 14 but not in humans. 25 A comparison with promoters of the two genes would be important to understand the mechanism of obesityinduced downregulation. Platt et al reported that a 56-bp DNA fragment between À687 and À743 upstream from the start of the adipsin gene contained the suppressive element of expression in adipose tissue of obese mice. 15 Further, this fragment was bound by proteins less abundantly present in nuclear extracts from obese mice than lean mice. They called the fragment ORE (obesity regulatory element). In comparison with the promoter of the adipsin gene, we identi®ed two octamer elements at À233aÀ226, CCCAAGCT, and À328aÀ321, TTGCCCCA, perfectly corresponding to the sequence in ORE. The two octamers may be cis-elements of negatively regulated genes in the development of obesity. Previously, several mutations in the adipose-speci®c genes have been described in humans with obesity. Genetic disruption of leptin causes obesity in humans as well as rodents. 26 Peroxisome-proliferator-activator receptor (PPAR)g2 is a nuclear receptor regulating the differentiation of adipocytes. Two missense mutations in the human PPARg2 gene have been reported. Constitutively active Pro 115 Gln mutation affects the Ser 114 phosphorylation site and is associated with obesity. 27 Some reports suggest the association of the Pro 12 Ala substitution with obesity, 28, 29 although the participation of the mutation in the development of obesity still remains controversial. 30 ± 32 Thus, mutations in adipose-speci®c genes may lead to obesity. In this study, we identi®ed two nucleotide changes in human adiponectin gene in 219 unrelated subjects. One was a G to T mutation at nucleotide 94 in exon 2 without any amino acid conversion and we found no association between this polymorphism and obesity. The other was a C to T mutation at nucleotide 383 in exon 3 with signi®cant amino acid conversion from arginine to cysteine (R112C) found in the non-obese subject with decreased plasma adiponectin level. The mutation was derived from the C to T transition occurred in CG dinucleotides regarded as hypermutable nucleotide in the human genome. 33 Although this mutation was rare, one daughter carrying this mutation also showed distinguishably decreased plasma adiponectin compared to the other siblings. The reason why this mutation causes the reduced plasma adiponectin level has been obscure in spite of their normal body mass indexes. This amino acid substitution will give rise to a change in ionic charge and conformation of the adiponectin protein, because the SH group has superseded an NH2 group. It is likely that the R112C substitution leads to the conformational change resulting in the reduction of plasma adiponectin concentration. In order to obtain de®nitive proof that the mutation presented here is responsible for the decreased plasma level, in vitro expression studies will be required.
The physiological function of adiponectin remains unclear to date. Adiponectin is a matrix-like protein with homology to collagens, 6 suggesting that it is secreted and anchored in the adipocyte milieu. This protein also has a structural similarity to complement factor C1q and thus belongs to the collectin family. It is well known that adipocytes secrete a variety of the factors in complement system including factor B, 34 C3, 35 adipsin (factor D), and acylation stimulating protein (ASP)aC3a. 36 Adiponectin may interact with these proteins and may promote the function of mature adipocytes such as triglyceride synthesis. The entrapment of adiponectin in the vicinity of adipocytes may be one of the mechanisms for decreased plasma concentration in obesity. Adiponectin is secreted into blood circulation may interact with vascular endotherial cells. Recently we found that adiponectin reduced the expression of adhesion molecules in endothelial cells. 37 Attachment of monocytes to endothelial cells is the ®rst step of atherogenic vascular changes. Decreased plasma adiponectin may contribute to the development of atherogenic vascular diseases in obesity. It is notable that the subject carrying R112C mutation with low levels of plasma adiponectin level suffered from coronary artery disease and lung thrombosis. We could not conclude the signi®cance of the mutation because it was found in only one patient. Further genetic study in a larger population will address the answer.
